Mr. Brady became the latest celebrity to try to preserve a pet’s genetics, a move that animal rights groups have criticized.
Zacks Investment Research on MSN
AnaptysBio, Inc. (ANAB) Surpasses Q3 Earnings and Revenue Estimates
AnaptysBio, Inc. (ANAB) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of a loss of $1.06 per share. This compares to a loss of $1.14 per share a year ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback